🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

High Impact Training to Patients with Prostate Cancer and Bone Metastases

RecruitingNAAges 18 Years - anyMaleCopenhagen University Hospital at Herlev
NCT06259279 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

HIP is a randomized controlled trial. The aim is investigate the effect, safety and feasibility of brief, high-impact exercise targeting bones in patients with prostate cancer and bone metastases. Furthermore, to investigate the effects of the intervention on bone status (bone mineral density) and body composition, physical function and performance, patient reported quality-of-life outcomes, falls and hospitalizations. The effects of resistance training on the antitumor immunity will be assessed in the peripheral blood and tumor biopsies (HIPimmune).

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients with metastatic hormone sensitive prostate cancer (mHSPC) * Patients must have bone metastases according to the most recent imaging (Bone scan, CT, MRI and/or PET) * Patients must be treated with androgen deprivation therapy (ADT) (orchiectomy, luteinizing hormone-releasing hormone (LHRH) agonist or antagonist treatment) started \< 12 months ago. Additional treatment in the mHSPC setting, i.e., radiotherapy (RT) of the prostate, novel hormone agents (NHA) and/or docetaxel is permitted * Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status score \<2 * Patients must be able to speak and read Danish and provide a signed informed consent form * Patients must be ambulatory without walking aids Exclusion Criteria: * Patients with any physical condition that interferes with the performance of physical exercise training * Patients with presence of any musculoskeletal, cardiovascular, or neurologic conditions that may prevent patients from exercising * Patients with bone pain requiring opioids * Patients with planned or prior palliative radiation therapy to the bone * Patients with major surgery within the past 6 months HIPimmune: all patients included in HIP are eligible for HIPimmune
💊

What it tests

  • High intensity high impact exercise intervention
📍

Where

1 site
Herlev and Gentofte Hospital
Herlev, Denmark
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy